Journal of psychosomatic research · 2025
Factors associated with new onset of depression and anxiety symptoms differ by sex in the COPDGene study.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Voorhies Kirsten, Fiedorowicz Jess G, Yohannes Abebaw M, Kinney Gregory L, DeMeo Dawn L, Regan Elizabeth A, Crapo James D, Silverman Edwin K, Lange Christoph, Hoth Karin F, Lutz Sharon M
Аннотация
OBJECTIVE: Examine clinical and demographic variables associated with new onset depression and anxiety symptoms and assess moderation by sex in COPDGene, a cohort study of current and former smokers at risk for or with chronic obstructive pulmonary disease (COPD).
METHODS: In the COPDGene study, 2653 adults had the hospital anxiety (HADS-A) and depression (HADS-D) scales available at phase 2 and 3, as well as clinical and demographic variables available at 2 and non-elevated HADS at phase 2. We defined new onset depression symptoms as HADS-D elevated at phase 3 (HADS-D ≥ 8) versus no new onset as HADS-D not elevated at either phase (HADS-D < 8). New onset anxiety symptoms were defined identically using HADS-A. We used logistic regression models among all participants and stratified by sex and assessed sex interactions for variables associated with the outcome for only one sex.
RESULTS: Among males, COPD Assessment test (CAT) score was positively associated with new onset depression (β = 0.08, p = 1.9 × 10-5) and anxiety (β = 0.06, p = 1.4 × 10-3) symptoms. Among females, the modified Medical Research Council (mMRC) dyspnea was positively associated with new onset anxiety symptoms (β = 0.33, p = 1.4 × 10-3). We found sex by CAT score (β = -0.06, p = 0.02) and sex by mMRC dyspnea (β = 0.42, p = 5.1 × 10-3) interactions on new onset anxiety symptoms, and sex by CAT score interaction (β = -0.05, p = 0.04) on new onset depression symptoms.
CONCLUSIONS: These findings highlight the importance of understanding factors that increase risk for depression and anxiety among smokers at risk for or with COPD and are moderated by sex.
METHODS: In the COPDGene study, 2653 adults had the hospital anxiety (HADS-A) and depression (HADS-D) scales available at phase 2 and 3, as well as clinical and demographic variables available at 2 and non-elevated HADS at phase 2. We defined new onset depression symptoms as HADS-D elevated at phase 3 (HADS-D ≥ 8) versus no new onset as HADS-D not elevated at either phase (HADS-D < 8). New onset anxiety symptoms were defined identically using HADS-A. We used logistic regression models among all participants and stratified by sex and assessed sex interactions for variables associated with the outcome for only one sex.
RESULTS: Among males, COPD Assessment test (CAT) score was positively associated with new onset depression (β = 0.08, p = 1.9 × 10-5) and anxiety (β = 0.06, p = 1.4 × 10-3) symptoms. Among females, the modified Medical Research Council (mMRC) dyspnea was positively associated with new onset anxiety symptoms (β = 0.33, p = 1.4 × 10-3). We found sex by CAT score (β = -0.06, p = 0.02) and sex by mMRC dyspnea (β = 0.42, p = 5.1 × 10-3) interactions on new onset anxiety symptoms, and sex by CAT score interaction (β = -0.05, p = 0.04) on new onset depression symptoms.
CONCLUSIONS: These findings highlight the importance of understanding factors that increase risk for depression and anxiety among smokers at risk for or with COPD and are moderated by sex.